glp-1 naion Popular Type 2 Diabetes Drug Associated with Increased Risk of Ozempic & GLP-1s Linked to

The 2nd GLP-1-Based Therapeutics Summit returns to tackle the challenges in best-in-class GLP-1 development and indication expansion with new clinical data, new preclinical data, and 18+ expert speakers including Eli Lily, Regeneron, Roche, Novo Nordisk, Fractyl Health and more at the forefront of the field

Patients have found compounded semaglutide to be a cheaper, accessible GLP-1, but health experts warn of risks tied to the non-FDA-approved drugs.

Orem, UT - June 9, 2026 - DietsMD.com, an online medical weight loss platform specializing in doctor-guided GLP-1

- ( )

Out-of-Pocket Costs Drive Abandonment Especially in Obesity While payer restrictions and coverage gaps contribute to GLP-1 therapy abandonment, out-of-pocket (OOP) costs remain the most consistent and powerful predictor of non-adherence